Literature DB >> 16509579

Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications.

Prasad Dande1, Thazha P Prakash, Namir Sioufi, Hans Gaus, Russell Jarres, Andreas Berdeja, Eric E Swayze, Richard H Griffey, Balkrishen Bhat.   

Abstract

A systematic structure-activity relationship study of 4'-thioribose containing small interfering RNAs (siRNAs) has led to the identification of highly potent and stable antisense constructs. To enable this optimization effort for both in vitro and in vivo applications, we have significantly improved the yields of 4'-thioribonucleosides by using a chirally pure (R)-sulfoxide precursor. siRNA duplexes containing strategically placed regions of 4'-thio-RNA were synthesized and evaluated for RNA interference activity and plasma stability. Stretches of 4'-thio-RNA were well tolerated in both the antisense and sense strands. However, optimization of both the number and placement of 4'-thioribonucleosides was necessary for maximal potency. These optimized siRNAs were generally equipotent or superior to native siRNAs and exhibited increased thermal and plasma stability. Furthermore, significant improvements in siRNA activity and plasma stability were achieved by judicious combination of 4'-thioribose with 2'-O-methyl and 2'-O-methoxyethyl modifications. These optimized 4'-thio-siRNAs may be valuable for developing stable siRNAs for therapeutic applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16509579     DOI: 10.1021/jm050822c

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  23 in total

Review 1.  RNA interference trigger variants: getting the most out of RNA for RNA interference-based therapeutics.

Authors:  Nicholas M Snead; John J Rossi
Journal:  Nucleic Acid Ther       Date:  2012-06       Impact factor: 5.486

Review 2.  Chemical modification: the key to clinical application of RNA interference?

Authors:  David R Corey
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  Effect of base modifications on structure, thermodynamic stability, and gene silencing activity of short interfering RNA.

Authors:  Katarzyna Sipa; Elzbieta Sochacka; Julia Kazmierczak-Baranska; Maria Maszewska; Magdalena Janicka; Genowefa Nowak; Barbara Nawrot
Journal:  RNA       Date:  2007-06-21       Impact factor: 4.942

4.  Unique gene-silencing and structural properties of 2'-fluoro-modified siRNAs.

Authors:  Muthiah Manoharan; Akin Akinc; Rajendra K Pandey; June Qin; Philipp Hadwiger; Matthias John; Kathy Mills; Klaus Charisse; Martin A Maier; Lubomir Nechev; Emily M Greene; Pradeep S Pallan; Eriks Rozners; Kallanthottathil G Rajeev; Martin Egli
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-31       Impact factor: 15.336

Review 5.  RNA therapeutics targeting osteoclast-mediated excessive bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Adv Drug Deliv Rev       Date:  2011-09-10       Impact factor: 15.470

Review 6.  Therapeutic potential of siRNA and DNAzymes in cancer.

Authors:  Hanuma Kumar Karnati; Ravi Shekar Yalagala; Rambabu Undi; Satya Ratan Pasupuleti; Ravi Kumar Gutti
Journal:  Tumour Biol       Date:  2014-08-23

Review 7.  Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.

Authors:  Prashant Kesharwani; Arun K Iyer
Journal:  Drug Discov Today       Date:  2014-12-31       Impact factor: 7.851

8.  7-Substituted 8-aza-7-deazaadenosines for modification of the siRNA major groove.

Authors:  José M Ibarra-Soza; Alexi A Morris; Prasanna Jayalath; Hayden Peacock; Wayne E Conrad; Michael B Donald; Mark J Kurth; Peter A Beal
Journal:  Org Biomol Chem       Date:  2012-07-05       Impact factor: 3.876

9.  Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters.

Authors:  Jonathan K Watts; Dongbo Yu; Klaus Charisse; Christophe Montaillier; Pierre Potier; Muthiah Manoharan; David R Corey
Journal:  Nucleic Acids Res       Date:  2010-04-19       Impact factor: 16.971

10.  Light-activated RNA interference using double-stranded siRNA precursors modified using a remarkable regiospecificity of diazo-based photolabile groups.

Authors:  Samit Shah; Piyush K Jain; Ashish Kala; Dipu Karunakaran; Simon H Friedman
Journal:  Nucleic Acids Res       Date:  2009-05-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.